11-7825914-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153445.2(OR5P3):āc.59A>Gā(p.Asp20Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000287 in 1,604,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_153445.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5P3 | NM_153445.2 | c.59A>G | p.Asp20Gly | missense_variant | 2/2 | ENST00000641167.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5P3 | ENST00000641167.1 | c.59A>G | p.Asp20Gly | missense_variant | 2/2 | NM_153445.2 | P1 | ||
ENST00000529488.5 | n.531+53093A>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000466 AC: 7AN: 150188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000287 AC: 7AN: 244164Hom.: 0 AF XY: 0.0000376 AC XY: 5AN XY: 133148
GnomAD4 exome AF: 0.0000268 AC: 39AN: 1454412Hom.: 0 Cov.: 33 AF XY: 0.0000262 AC XY: 19AN XY: 724002
GnomAD4 genome AF: 0.0000466 AC: 7AN: 150188Hom.: 0 Cov.: 32 AF XY: 0.0000545 AC XY: 4AN XY: 73436
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2023 | The c.59A>G (p.D20G) alteration is located in exon 1 (coding exon 1) of the OR5P3 gene. This alteration results from a A to G substitution at nucleotide position 59, causing the aspartic acid (D) at amino acid position 20 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at